Navigation Links
Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
Date:7/16/2009

VANCOUVER, July 16 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX) has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) Long Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) designed for long lesions. At 38 mm, it is the longest available DES, providing doctors an option that can potentially reduce the number of stents used in more complex cases, simplifying procedures and reducing costs. It affords a more efficient treatment option for the estimated 8 to 10 percent(1) of patients with long lesions. Boston Scientific plans to launch the product in the U.S. next month. It received CE Mark approval in 2007.

"The TAXUS Liberte Long Stent offers physicians and patients distinct advantages compared to using two overlapping drug-eluting stents," said Mark Turco, M.D., FACC, FSCAI, Director of the Center for Cardiac Vascular Research at Washington Adventist Hospital, Takoma Park, Maryland. "In the ATLAS Long Lesion Trial, the 38 mm TAXUS Liberte Stent significantly reduced myocardial infarction when compared to the TAXUS(R) Express(R) Stent, making the TAXUS Liberte Long Stent an attractive option for interventional cardiologists faced with long, challenging lesions."

The TAXUS ATLAS Long Lesion Trial reported a significant 79 percent reduction in the rate of nine-month myocardial infarction for the TAXUS Liberte Long Stent as compared to the TAXUS Express Stent control (1.3% vs. 6.3%, p=0.026). At two years, the composite measure of cardiac death or myocardial infarction showed a significant 63 percent reduction for the TAXUS Liberte Long Stent compared to
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
2. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
3. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
4. Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
5. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
6. Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line
7. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
8. Angiotech announces date of annual general meeting of shareholders
9. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
10. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
11. Angiotech announces positive results from Bio-Seal(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... quickly produce ultra-lightweight, bendable batteries and supercapacitors in ... a sheet of paper with ink made of ... conductive storage device, said Yi Cui, assistant professor ... needs a low-cost, high-performance energy storage device, such ...
... 7 Vivakor, Inc. (OTC Bulletin Board: VIVK) today announced ... Chen and Fritz Lin, M.D. , Dr. Francis Chen ... as Board member of Vivakor, having held senior management positions ... Dr. Chen earned his Ph.D. in immunology from Harvard University, ...
... , VIENNA, Austria, December 7 ... for the,chemical industry, announced today that it has appointed Mr ... forward, EUCODIS Bioscience,sole focus will be to provide high-performance enzymes ... and,on its proven technology of "in vivo recombination". , ...
Cached Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 3EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2
(Date:4/16/2014)... Armand-Frappier has just received a research grant from the ... nearly US$600,000. The 5-year grant is to pursue cutting-edge ... and to explore their biomedical potential in the field ... , "Receiving a grant at this level ... president of research and academic affairs at INRS. "It ...
(Date:4/16/2014)... array of finger-like projections called microvilli covers ... intestines., Vanderbilt University researchers have now discovered how ... critical for absorbing nutrients and defending against pathogens. ... Cell , reveal a role for adhesion ... understanding of intestinal pathologies associated with inherited and ...
(Date:4/16/2014)... memories improves during childhood, associated with structural changes ... and parietal cortices. New research from UC Davis ... this crucial time. Eventually, that could give insights ... into and during adolescence and affect memory, such ... the middle of the brain, the hippocampus plays ...
Breaking Biology News(10 mins):High-level NIH grant goes to professor Nicolas Doucet of INRS 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3How kids' brain structures grow as memory develops 2
... To arrange for an interview with a researcher, please contact ... of each tip. For more information on ORNL and its research ... If you have a general media-related question or comment, you can ... -- Battling bugs . . . The software-writing ...
... have discovered a novel mechanism in Salmonella that ... its production of proteins in a previously unheard of manner. ... of certain proteins to respond to inhospitable conditions. ... were intrigued to find evidence of a similar mechanism in ...
... 29, 2010): Today, the Association for Molecular Pathology (AMP) submitted ... by the National Institutes of Health (NIH) for its Genetic ... membership to formulate a comprehensive response to the RFI. ... laboratory setting, AMP is able to inform the NIH on ...
Cached Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 2Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 3Story tips from the Department of Energy's Oak Ridge National Laboratory, August 2010 4Mechanism uncovered behind Salmonella virulence and drug susceptibility 2Mechanism uncovered behind Salmonella virulence and drug susceptibility 3Mechanism uncovered behind Salmonella virulence and drug susceptibility 4AMP responds to Genetic Test Registry request for information 2
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. ID clarifier: tissue-culture treated ... cm 2 D H 245 ...
BD BioCoat Collagen IV 150 mm Culture Dishes...
...
...
Biology Products: